Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 923093 STAMFORD, CT

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
650,000
+202.3% QoQ
Ownership
0.508%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
15 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
42,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 650,000
2025-12-31 42,700
2025-12-31 215,000
2025-09-30 36,200
2025-09-30 12,900
2025-03-31 10,800
2025-03-31 52,980
2024-12-31 8,500
2024-12-31 9,200
2024-09-30 73,002
2023-12-31 9,962
2023-09-30 50,112
2023-06-30 7,398
2022-06-30 34,707
2022-03-31 48,840
2021-09-30 150,703
2021-06-30 22,638
2020-12-31 29,448
2020-09-30 19,941